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Abstract
Aim: To test whether the number of teeth, an inverse proxy for composite oral
infection scores is associated with better survival.
Materials and Methods: The Kuopio Oral Health and Heart study initiated a
case–control study in 1995–1996 consisting of 256 consecutive coronary artery
disease patients and 250 age and gender-matched controls. We appended the mor-
tality data and formulated a longitudinal study. By May 31st, 2011, 124 mortali-
ties had occurred and 80 of which were of cardiovascular origin. Using Cox
proportional hazards models, we assessed the association of the teeth group
(Teethgrp) – consisting of 10 teeth – with cardiovascular and all-cause mortality
after 15.8 years of median follow-up.
Results: In multivariate models, with the edentulous state as reference, one level
increase in Teethgrp was associated with significantly increased survival from
cardiovascular disease (CVD) mortality with a Hazard Ratio (HR) 0.73, p-
value = 0.02 but not with all-cause mortality (HR = 0.87, p = 0.13). The findings
were not mediated by C-reactive protein (CRP) levels ≥3 mg/L or by median
fibrinogen levels, but were mediated by CRP levels >5 mg/L.
Conclusion: Each increment of 10 teeth from the edentulous state was associated
with a 27% improved CVD survival, independent of low-grade systemic
inflammation.
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Infections (Minick et al. 1979),
including oral infections (Beck et al.
1996, Janket et al. 2004) may con-
tribute to atherosclerosis and subse-
quent cardiovascular disease (CVD),
the most important cause of death
worldwide (AHA 2009). Oral health
has been shown to be predictive of
all-cause mortality (Garcia et al.
1998, Morita et al. 2006) and tooth
loss has been associated with cardio-
vascular mortality (Tu et al. 2007,
Watt et al. 2010). Inflammation may
be the causative biological process in
mortality (Reuben et al. 2002, Ham-
alainen et al. 2003). However, the
ageing process itself is also associ-
ated with inflammation (Schrager
et al. 2007, Cartier et al. 2009) and
in the inflammatory states, choles-
terol is depressed (Salanitro et al.
2012). This inverse association of
cholesterol and inflammation was
supported by several reports where
low cholesterol levels and high
C-reactive protein (CRP) levels pre-
dicted mortality(Reuben et al. 1999)
(Van Hemelrijck et al. 2012).
The number of teeth has been
presumed to impact systemic health
via nutrition (Ritchie et al. 2000)
and inflammation (Beck & Offenb-
acher 2005). The number of remain-
ing teeth was inversely associated
with previous oral infections which
may contribute to the pathogenesis
of cardiovascular diseases (Burt
et al. 1990, Joshipura et al. 2003).
The number of remaining teeth may
be the results of past oral infections
and in this cohort, it demonstrated a
significant inverse association with
composite oral infection score
(r = 0.8, p < 0.0001). Given the
close correlation of oral health with
several systemic inflammatory dis-
eases, (Qvarnstrom et al. 2008, 2010)
we postulated that remaining teeth
may serve as a simple and practical
predictor for mortality without any
laboratory tests or venipuncture.
Although some oral infections such
as pericoronitis or root remnants
generated powerful inflammation in
our previous study (Janket et al.
2004), not everyone has these spe-
cific infections. Meanwhile, the ubiq-
uitous presence of teeth will assess
the population risk better than the
composite oral infection score in
public health perspectives. Thus, we
chose the number of teeth, an
inverse proxy for oral inflammation
burden, as our predictor. The
primary aim of this study was to
investigate whether the number of
remaining teeth at baseline, as an
inverse proxy for oral inflammation,
would predict CVD and all-cause
mortality in 15 years and longer fol-
low-up. The secondary aim was to
evaluate whether the relationship of
remaining teeth to mortality was
independent of systemic inflamma-
tion assessed by CRP or fibrinogen
by mediation analyses.
Materials and methods
Ethical and human subjects’ protection
This study was approved by the
Joint Ethical Committee of the
Kuopio University Hospital and the
University of Kuopio, and written
informed consent was obtained from
all participants. The longitudinal
portion of the study was approved
by the Boston University Institu-
tional Review Board. This project
adhered to the guidelines set forth
by the Declaration of Helsinki and
the Belmont Accord to ensure the
safety of human research subjects.
Study population
Kuopio Oral Health and Heart
(KOHH) study was initiated as a
cross-sectional study in 1995–1996 to
investigate the association between
oral health and coronary artery dis-
ease (CAD) in Kuopio, Finland. For
this study, we merged mortality
outcome to the baseline data consist-
ing of 256 CAD patients and 250
age- and sex-matched controls with
a mean age of 60 and created a
prospective follow-up study.
At baseline, 256 consecutive car-
diac patients at Kuopio University
Hospital who were referred for coro-
nary angiography and confirmed as
having CAD were invited to partici-
pate in the KOHH study. The CAD
diagnosis was determined by the
presence of at least 50% stenosis in
one of the epicardial arteries. Poten-
tial subjects were excluded if they
took antibiotics during the previous
30 days or had chronic infection
other than dental disease. Also
recruited were 250 age- and gender-
matched controls who were admitted
to the general surgery or otorhino-
laryngology (ORL) departments at
the same hospital for elective sur-
gery. They were considered as not
having heart disease based on their
medical history and pre-admission
electrocardiogram (ECG). The
controls were recruited from the
population of the same catchment
area where the cases arose and
would have come to the same hospi-
tal if they had developed heart dis-
ease. The same exclusion and
inclusion criteria were applied to
non-cardiac patients. Additional
exclusion criteria were as follows: (1)
those who needed emergency coro-
nary by-pass surgery or valvular
replacement surgery; (2) those whose
disease status was so grave that a
dental examination or dental x-ray
could not be performed safely and (3)
those who required antibiotic prophy-
laxis prior to periodontal probing.
Further details regarding this cohort
have been published elsewhere (Janket
et al. 2004, 2006, Qvarnstrom et al.
2008, 2010) (http://www.ncbi.nlm.nih.
gov/pubmed/14967717; http://www.
ncbi.nlm.nih.gov/pubmed/20666873;
http://www.ncbi.nlm.nih.gov/pubmed/
20177131).
Exposure assessment
At the beginning of the study (1995–
1996), a single examiner (MS)
performed all clinical dental examin-
ations and pantomographic radiol-
ogy examinations following the
World Health Organization format
(Ainamo et al. 1982). The number of
teeth as a predictor in this study
included sound or repaired teeth
excluding non-restorable root tips.
Dental infections such as periapical
lesions that generally signify long
standing dental caries, pericoronitis
defined as infection/inflammation
surrounding 3rd molars, (radiolucent
follicle around the retained or erupt-
ing third molars with diameter
>3 mm in the pantomogram), or
numbers of root remnants with soft
tissue inflammation (dental hard tis-
sues are usually destroyed by
advanced dental caries leaving only
tips of the root), amount of vertical
bone loss (measured from cemento-
enamel junction in mm), calculus
deposits and restorations with over-
hangs were recorded. The details of
dental examinations have been pub-
lished elsewhere (Janket et al. 2004).
The two pantomogram readings by
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this examiner (MS) exhibited an
excellent agreement (kappa = 0.9).
Ascertainment of the endpoints
The outcome, CVD mortality, has
been assessed using the mortality
records obtained from the Finnish
Death Registry in 2008, 2009, 2010
and 2011. ICD-10 codes I00 and I99
were considered deaths due to cardiac
causes and the most prevalent one
was I25 (chronic ischaemic heart dis-
ease). Each resident of Finland has a
unique identifier number and the
Office of Statistics Finland collects all
health data including mortality. The
reliability of mortality data was deter-
mined to be 99% after comparing
2009 and 2011 records in a random
sample of 100 records. The validity of
mortality records was tested by com-
paring them to the physician’s diag-
nosis of death from the medical
records. In 100 records we examined,
we observed three disagreements in
ICD-10 codes, but upon further
detailed investigation, all turned out
to be in agreement. For example, the
Finnish death registry listed one case
as “I21.4: Acute subendocardial myo-
cardial infarction”, whereas physi-
cian’s diagnosis of death was “I25.1:
Atherosclerotic heart disease”. In the
second case, mortality record showed
as “I21.9: Acute myocardial infarc-
tion, unspecified” whereas physician’s
diagnosis for death was “I70.9: Gen-
eralized and unspecified atherosclero-
sis”. Thus, although ICD-10 codes
were different in these cases, they
described the same pathology with
different codes. Thus, validity was
judged to be 100%.
Confounding factor
Age in years and smoking in three
categories (never-smokers, current
smokers and past smokers) were
assessed. Weights were measured
without shoes and in light clothing.
Heights were measured without
shoes using a stadiometer with
Frankfort plane in a horizontal posi-
tion. Body mass index (BMI) was
calculated by weight in kg divided
by squared height in metres. Total
cholesterol (TC), triglyceride (TG)
and high-density lipoprotein choles-
terol (HDL) were measured by the
automated enzymatic technique.
Low-density lipoprotein cholesterol
levels were estimated by the Friede-
wald formula (Warnick et al. 1990).
Hypertension (HTN) and diabetes
were ascertained by medical record
review by one of the authors (MS).
Subjects were categorized as hyper-
tensive or diabetic if their medical
records documented these diagnoses
or their treatments.
Assessment of the mediators
Fibrinogen was measured by the
Clauss method and CRP was mea-
sured by immuno-turbidimetry utiliz-
ing the HITACHI 717 analyzer
(Boehringer Mannheim, Mannheim,
Germany). This method was not the
hs-CRP assay and the lowest sensitiv-
ity level was 1.0 mg/L. In the clinical
context, this method has been proven
to be comparable to hs-CRP assay
(Rifai et al. 2006). The reported
Coefficient of Variation (CV) for
CRP assay was between 8.1 and
11.4% (Sung et al. 2002, Aziz et al.
2003). All blood samples were col-
lected after fasting if required and
analysed immediately in the hospital
laboratory. The analyses were per-
formed in batches including both
cases and controls to evenly distrib-
ute any potential environmental
changes and measurement variability.
Statistical analysis
Using Statistical Analysis System
(SAS Institute Inc., Cary, NC, USA)
version 9.1, the basic characteristics
such as mean age, sex, smoking sta-
tus, body mass index, number of
teeth and cholesterol subgroup levels
were compared between those who
died during the follow-up and who
survived. In the bivariate analyses,
chi square tests or non-parametric
Kruskal–Wallis tests were used to
make three group comparisons. In
multivariate analyses, we used Cox
proportional hazard modelling after
testing the proportional hazard
assumption. Because the log-hazard
ratio for CVD survival and the num-
ber of teeth appeared to be non-lin-
ear, we categorized the number of
teeth in four groups: the number of
teeth (Nteeth) = 0; 0 < Nteeth ≤ 10;
10 < Nteeth ≤ 20; Nteeth > 20 and
evaluated the relationship of the
Nteeth groups to mortality. To pre-
vent model saturation in ancillary
models with CRP and fibrinogen, we
omitted the two most uninformative
variables, sex (HR = 1.03, p = 0.93)
and education (HR = 1.00, p = 0.98).
This is justified judging from model 2
(in Table 4) without these two vari-
ables did not materially alter the
parameter estimates in the fully
adjusted model 3 (in Table 4) that
included these variables. In the car-
diovascular mortality modelling,
non-CVD deaths were censored. The
established confounding factors such
as age, sex, smoking, total cholesterol
to HDL ratio (T/H ratio), HTN, dia-
betes and education were controlled.
Although 82.6% of CVD mortality
occurred in individuals who had
diagnosis of CAD at baseline, to for-
mally test whether baseline CAD sta-
tus is confounder or collinear factor,
we adjusted baseline CAD in the
modelling. Although our primary
interest was CVD mortality, we also
conducted analyses for the prediction
of all-cause mortality.
We further tested whether the
relationship of mortality and the
Nteeth groups were mediated by sys-
temic inflammation or systemic
thrombosis by conducting formal
mediation analyses according to the
methods described by Fritz and
MacKinnon (2007) and Jasti et al.
(2008). The requirement(s) for the
presence of mediation by CRP or
fibrinogen are the following:
• The total effect of X, (Number of
teeth) on Y (CVD mortality (s)
must be significant.
• The effect of X (Number of
teeth) on M, (CRP or Fibrino-
gen) (a) must be significant.
• The effect of CRP or Fibrinogen
on Y (CVD mortality) controlled
for Number of teeth (b) must be
significant.
• The direct effect of “Number of
teeth” on “CVD mortality”
adjusted for “CRP or fibrinogen”
(s′) must be non-significant.
Y ¼ u1 þ sX eqn1
M ¼ u2 þ aX eqn2
Y ¼ u3 þ0 s0Xþ bM eqn3; 4
Therefore, if the mediation effect is
significant, s’ must be non-significant
while b must be significant in equa-
tion (3), (4). where s is the estimate
of the total effect of X on Y, s’ is
the estimate of the direct effect of X
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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on Y adjusted for M, b is the esti-
mate of the effect of M on Y
adjusted for X and a is the estimate
of the effect of X on M. φ1, φ2 and
φ3 are the intercepts. In our study
Y = CVD mortality, X = number of
teeth and M = CRP or fibrinogen.
If all four criteria are satisfied, we
then tested the mediation by the So-
bel test. We also tested whether daily
tooth brushing, flossing and regular
dental check-ups would be associ-
ated with CVD mortality by stochas-
tically combining these variables and
created an Oral Care Index (OCI).
OCI was the sum of weighted score
from a logistic model predicting sur-
vival from CVD. Tooth Brushing
was not informative (everyone was
doing it) and dropped from the
model. We weighted daily flossing by
7, dental appointment within the
past year by 1.2 and going to a
private dentist in Finland by 1.6.
Sommerfelt et al. (2012) raised
concerns that studies started as case–
control format and extended to longi-
tudinal studies such as ours may
over-estimate the true risk. There-
fore, we estimated the population
risk by increasing the controls by
computer simulation to be similar to
the age-specific population in Finland
with CHD prevalence of 20% which
was reported (Kattainen et al. 2006).
Results
By May 31st, 2011, of 505 KOHH
study participants (one subject was
lost during the follow-up), 124 mor-
talities were documented. Of these
mortalities, 80 were cardiovascular
deaths with documented ICD-10
codes I00–I99. Given a 50% of the
baseline prevalence of CAD, high
CVD mortality was expected. When
we restricted our analyses to those
without missing values, the final
sample size decreased to 473, the
number of CVD mortalities to 69
and all-cause mortalities to 110.
Non-CVD deaths, censored in the
CVD mortality analyses, were
mostly from cancer followed by
respiratory disease, Alzheimer’s
disease, depression and suicide.
Table 1 displays non-parametric
Spearman correlations between
several important biomarkers. The
number of teeth was inversely corre-
lated with various inflammatory
markers. Specifically, both CRP and
fibrinogen were significantly associ-
ated with number of teeth (r = 0.29,
p < 0.0001; r = 0.28, p < 0.001
respectively). The baseline character-
istics for the three groups are pre-
sented in Table 2. Most cardiac risk
factors such as age, smoking, HTN,
diabetes, CRP and education were
significantly different between the
survivors and non-survivors of the
CVD. However, unlike in younger
cohorts, BMI was lower among the
non-survivors.
In age-, sex- and smoking-
adjusted Kaplan–Meier curves dem-
onstrated that the association of the
increased number of teeth with better
CVD survival in males (Fig. 1) and
females (figure not presented). In
Table 3, number of event, total per-
son-years and incidence rates strati-
fied by the number of teeth groups
are presented. A trend for improved
survival in both CVD and all-cause
mortality was evident, but the gradi-
ent of all-cause mortality was less
steep and was not significant
(p = 0.08). In fully adjusted multivar-
iate models controlling for age, sex,
smoking (never, past and current
smokers), HTN, total/HDL choles-
terol ratio, diabetes and education
(in years), each 10 tooth increment
from the edentulous state was associ-
ated with an approximately 27%
increased survival rate from CVD
death (Table 4, model 3). Besides the
number of teeth, age, total/HDL
cholesterol ratio and smoking were
the significant predictors of CVD
mortality. Controlling for education
in three categories (low, medium,
high) did not substantially alter the
results. When we tested whether the
baseline CAD status is a collinear
factor or a confounding by adjusting
baseline CAD status in the model-
ling, the number of teeth lost its sig-
nificance, HR = 0.72 (0.49–1.05),
p = 0.09. These results suggested that
the baseline CAD is on the causal
pathway to CVD mortality.
In fully adjusted model, all-cause
mortality was not statistically signifi-
cant (HR = 0.82, p = 0.13). Unlike
CVD mortality, diabetes in addition
to age and smoking were signifi-
cantly associated with all-cause
mortality. These results are pre-
sented in Table 5.
Table 1. Non-parametric Spearman Correlation Matrix of inflammatory markers
Score
Rho*
(p-value)
CRP
Rho
(p-value)
LDL
Rho
(p-value)
HDL
Rho
(p-value)
Trigly
Rho
(p-value)
Fibrino
Rho
(p-value)
BMI
Rho
(p-value)
Number of teeth* 0.79
(<0.0001)
0.29
(<0.0001)
0.04
(0.37)
0.12
(0.006)
0.11
(0.01)
0.28
(<0.0001)
0.02
(0.66)
Asymptotic dental infection Score (Score) 1 0.25
(<0.0001)
0.08
(0.09)
0.14
(0.002)
0.10
(0.02)
0.24
(<0.0001)
0.018
(0.69)
C-reactive protein (CRP) (mg/L) 1 0.11
(0.01)
0.26
(<0.0001)
0.25
(<0.0001)
0.22
(<0.0001)
0.16
(0.0003)
LDL cholesterol (LDL) (mmol/L) 1 0.21
(<0.0001)
0.02
(0.65)
0.13
(0.004)
0.002
(0.97)
HDL cholesterol (HDL) (mmol/L) 1 0.48
(<0.0001)
0.10
(0.02)
0.15
(0.001)
Triglyceride (Trigly) (mmol/L) 1 0.06
(0.2)
0.25
(<0.0001)
Fibrinogen (Fibrino) (g/L) 1 0.0002
(0.99)
*Rho: Spearman’s non-parametric correlation coefficient
Significant correlations are in bold.
Juxtaposing correlations are in blank. The correlation of HDL to CRP is the same as CRP to HDL.
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The results of mediation analyses
indicated that CRP ≥3 mg/L or
fibrinogen 3 g/L did not mediate the
relationship of the number of teeth to
the CVD mortality because the num-
ber of teeth retained its significance
even when these mediators were con-
trolled (Mediation test criteria 3 and
4 were not satisfied). Meanwhile, at
the CRP level >5 mg/L, we observed
a significant (0.013) mediation effect
of CRP on the relationship of the
number of teeth to CVD mortality
(Table 6). Approximately, 25.7% of
total effects of the tooth count on
CVD mortality were mediated by
CRP levels >5 mg/L. Adjusting good
oral care (top 25% of oral care index)
further improved CVD survival to
HR = 0.68, p = 0.03. Similar to the
previous report (Paganini-Hill et al.
2011), top 25% of OCI was signifi-
cantly associated with improved
CVD survival (HR = 0.41, p = 0.04),
but when the number of teeth entered
the model, it lost its significance sug-
gesting OCI was mediated by the
number of teeth. The population risk
estimates in the simulated data did
not change materially from the origi-
nal results with HR = 0.73 (0.61–
0.88), p-value = 0.001.
Discussion
In this study of 473 persons, with
median follow-up of over 15.8 years,
each 10 tooth increment from the
edentulous state was associated with
a significantly improved survival rate
from cardiovascular death by
approximately 27% controlling for
age, smoking, total/HDL cholesterol
ratio, HTN, diabetes and education.
Although several previous stud-
ies investigated oral health and
mortality, most of them adjusted
confounding factors inadequately.
Only recently, results of longitudi-
Table 2. Baseline characteristics of the cohort
Alive
n = 363
Died of non-CVD
n = 41
Died of CVD
n = 69
p-value
Age,
Median (inter-quartile range)
59.0 (51–65) 64 (59–70) 67 (62–70) <0.0001*
Sex (n, %)
Men 224 (61.7%) 28 (68.3%) 47 (68.1%) 0.42
Women 139 (38.3%) 13 (31.7%) 22 (31.9%)
Body Mass Index (BMI) 24.7 24.7 23.8 0.10
Median (inter-quartile range) (22.9–27.0) (23.2–26.2) (22.1– 26.0)
Smoking, n (%)
Never
Current
Past
259 (71.3%)
36 (10%)
68 (18.7%)
29 (70.7%)
5 (12.2%)
7 (17.1%)
30 (43.5%)
7 (10.1%)
32 (46.4%)
<0.0001
0.86
<0.0001
% with Baseline CAD diagnosis 172 (42.6%) 12 (29.3%) 57 (82.6%) 0.0001*
Hypertension, (%) 116 (32%) 10 (24.4%) 32 (52.9%) 0.0009*
Diabetes, (%) 28 (7.7%) 6 (14.6%) 16 (22.9%) 0.0005*
Education (years) Median (inter-quartile range) 11 (10–14) 11 (9–14) 11 (9–12) 0.03*
LDL cholesterol (mmol/L) Median (inter-quartile range) 3.6 (3.1–4.3) 3.77 (3.1–4.5) 3.4 (3.1–4.2) 0.61
Triglyceride (mmol/L)
Median (inter-quartile range)
1.7 (1.23–2.3) 1.5 (1.2–1.9) 1.9 (1.2–2.5) 0.09
HDL cholesterol (mmol/L)
Median (inter-quartile range)
1.2 (0.98–1.4) 1.2 (1.0–1.4) 1.1 (0.9–1.3) 0.05*
Total/HDL cholesterol ratio
Median (inter-quartile range)
4.8 (4.0–5.7) 4.6 (3.9–5.3) 5.4 (4.3–6.2) 0.06
CRP (mg/L)
Median (inter-quartile range)
5.0 (4.0–10.0) 5.0 (4–8) 9.0 (6–15) 0.001*
Fibrinogen (g/L)
Median (inter-quartile range)
2.9 (2.6–3.3) 3.0 (2.7–3.5) 3.3 (2.9–3.9) 0.001*
*Significant at the a-level of 0.05.
Fig. 1. Survival prediction from CVD mortality by the teeth groups among 60-year-
old smoking males.
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nal studies with reasonable con-
founding adjustment have been
published (Schwahn et al. 2012,
Janket et al. 2013). As far as we
know, our study is the first study
that formally tested whether the
relationship of the number of teeth
to CVD mortality was mediated by
systemic inflammation as assessed
by fibrinogen and CRP levels. The
mediation effects by low levels of
systemic inflammation (CRP ≥ 3
mg/L) or systemic thrombosis were
not statistically significant. How-
ever, at much higher levels of CRP
(>5 mg/L), there appeared to be
mediation effects.
Alternatively, good oral health
may improve cardiac outcomes by
dietary benefits. (Nowjack-Raymer
& Sheiham 2003) As discussed in a
Table 3. Number of mortalities and the incidence rates stratified by the teeth groups
Number of teeth(0)
n = 117
Number of teeth(1–10)
n = 117
Number of teeth(11–20)
n = 72
Number of teeth(>20)
n = 167
Number of cardiac deaths 35 24 10 11
Number of all-cause deaths 46 33 15 30
Total person-years (p/y)* 1752.74 1846.28 1147.93 2656.04
CVD mortality Incidence rate (per
1000 p/y)
20 13 9 4
All-cause mortality Incidence rate
(per 1000 p/y)
26 18 13 11
*p/y: person-years.
Table 4. Multivariate proportional hazard models predicting cardiovascular mortality by the teeth groups
Exposure Hazard ratio
(95% confidence interval)
p-value
Model 1 Group 1 (Nteeth = 0)* 1.0 (reference) –
Group 2 ((0 < Nteeth ≤ 10) 0.90 (0.50–1.61) 0.71
Group 3 (10 < Nteeth ≤ 20) 0.62 (0.28–1.39) 0.24
Group 4 (Nteeth > 20) 0.31 (0.10–0.70) 0.005
As a trend across the groups 0.70 (0.56–0.89) 0.003†
Model 2 Group 1 1.0 (reference) –
Group 2 1.05 (0.58–1.90) 0.89
Group 3 0.62 (0.28–1.38) 0.24
Group 4 0.37 (0.17–0.84) 0.02
As a trend across the groups 0.73 (0.57–0.94) 0.02†
Model 3 Group 1 1.0 (reference) –
Group 2 1.06 (0.62–1.93) 0.85
Group 3 0.62 (0.27–1.41) 0.24
Group 4 0.37 (0.17–0.85) 0.02
As a trend across the groups 0.73 (0.58–0.93) 0.02†
Model 4
(Additional CRP>3 mg/L adjusted)
Group 1 1.0 (reference) –
Group 2
Group 3
1.12 (0.59–2.03)
0.65 (0.29–1.45)
0.83
0.29
Group 4 0.40 (0.17–0.89) 0.02
As a trend across the groups 0.75 (0.57–0.97) 0.03†
Model 5
(Additional CRP>5 mg/L adjusted)
Group 1 1.0 (reference) –
Group 2 1.18 (0.65–2.15) 0.58
Group 3 0.74 (0.33–1.65) 0.46
Group 4 0.47 (0.21–1.07) 0.07
As a trend across the groups 0.80 (0.57–0.94) 0.09†
Model 6
(Additional Fibrinogen > 3 g/L adjusted)
Group 1 1.0 (reference) –
Group 2 1.06 (0.59–1.92) 0.83
Group 3 0.64 (0.29–1.44) 0.28
Group 4 0.40 (0.18–0.90) 0.03
As a trend across the groups 0.75 (0.58–0.96) 0.02†
*Nteeth = number of teeth
†Denotes significant at the a-level of 0.05.
Model 1 adjusted for age, sex and smoking.
Model 2 adjusted for age, smoking (never, past and current smokers), hypertension, diabetes and Total/HDL cholesterol ratio.
Model 3 adjusted for age, sex, smoking (never, past and current), hypertension, diabetes, Total/HDL cholesterol ratio and education (in
years).
Model 4 adjusted for all the covariates adjusted in model 2 and CRP ≥ 3 mg/L.
Model 5 adjusted for all the covariates adjusted in model 2 and CRP > 5 mg/L.
Model 6 adjusted for all the covariates adjusted in model 2 and fibrinogen > median (3.0 gm/L).
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previous study (Schwahn et al.
2012), without a healthy dentition,
individuals cannot ingest healthy
foods that are low in glycemic index
(Janket et al. 2008) and high in
fruits and vegetables (Liu et al.
2004) which may lead to obesity,
diabetes and subsequent CVD. (Jan-
ket et al. 2008) Thus, it appears that
a good dentition is a prerequisite for
good nutrition that may lead to
overall good health. However,
adjusting dietary benefits are inap-
propriate because diet is an interme-
diate outcome on the causal
pathway (Tu et al. 2007).
Sommerfelt et al. (2012) raised an
interesting issue of potential risk
Table 5. Multivariate proportional hazard models predicting all-cause mortality by the teeth groups
Exposure Hazard ratio
(95% confidence interval)
p-value
Model 1 Group 1 (Nteeth = 0) 1.0 (reference) –
Group 2 ((0 < Nteeth ≤ 10) 0.99 (0.61–1.16) 0.95
Group 3 (10 < Nteeth ≤ 20) 0.69 (0.36–1.30) 0.25
Group 4 (Nteeth > 20) 0.67 (0.40–1.21) 0.13
As a trend across the groups 0.86 (0.72–1.00) 0.08
Model 2 Group 1 1.0 (reference) –
Group 2 1.04 (0.64–1.71) 0.86
Group 3 0.68 (0.36–1.29) 0.24
Group 4 0.74 (0.44–1.25) 0.26
As a trend across the groups 0.87 (0.73–1.04) 0.13
Model 3
(Additional CRP>3 mg/L adjusted)
Group 1 1.0 (reference) –
Group 2 1.09 (0.66–1.78) 0.75
Group 3 0.70 (0.37–1.34) 0.28
Group 4 0.76 (0.45–1.30) 0.32
As a trend across the groups 0.88 (0.733–1.06) 0.18
Model 4
(Additional Fibrinogen >3 g/L adjusted)
Group 1 1.0 (reference) –
Group 2 1.05 (0.64–1.72) 0.85
Group 3 0.70 (0.37–1.33) 0.28
Group 4 0.79 (0.47–1.35) 0.39
As a trend across the groups 0.89 (0.74–1.07) 0.22
Model 1 simultaneously adjusted for age, sex and smoking (never, past and current).
Model 2 simultaneously adjusted for age, sex, smoking (never, past and current), hypertension, Total/HDL cholesterol ratio, diabetes and
education (in years).
Model 3 simultaneously adjusted all covariates in model 2 plus CRP >3 mg/L.
Model 4 simultaneously adjusted all covariates in model 2 plus fibrinogen > median (3.0 g/L).
Table 6. Mediation analyses of CRP on the relationship of number of teeth and CVD mortality
Parameter Estimate SE p-value
Model 1.
At the cut-off CRP level 3 mg/L
Equation 1
(s)
Number of
teeth
0.30 0.15 0.04
Equation 2
(a)
Number of
teeth
0.17 0.12 0.16
No need to proceed because equation 2 is not significant. Suggests that mediation by CRP 3 mg/L is not present.
Parameter Estimate SE p-value
Model 2.
At the cut-off CRP level 5 mg/L
Equation 1
(s)
Number of
teeth
0.30 0.15 0.04
Equation 2
(a)
Number of
teeth
0.39 0.10 <0.0001
Equation 3
(b)
CRP ≥ 5
mg/L
1.10 0.34 0.001
Equation 4
(s′)
Number of
teeth
0.19 0.15 0.19
All 4 criteria for mediation analyses are satisfied. Proceed to Sobel mediation test.
Test
statistic
SE p-value
Sobel’s test 2.5 0.17 0.013
All mediation equations were controlled for age, sex, smoking, hypertension, Total/HDL cholesterol ratio, diabetes and education.
Bold significant at the a-level of 0.05 after 0.013.
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amplification in the case–control
studies that subsequently have been
extended to longitudinal studies.
However, our simulated results did
not appear to support his theory.
We disagree with Sommerfelt et al.
(2012) on the following basis.
● Relative risk amplification is not
uniform in all studies and may vary
depending on the specific outcomes
and the explanatory variables.
● The exposure in our study is not
clearly divided between cases and
controls. Unlike the binary vari-
able such as “pregnant” and “not
pregnant”, the controls in our
study are also exposed in some
degree because they have some
teeth. Thus, the exposure contrast
is not as drastic in our study.
● The outcome, cardiac deaths, is
also prevalent in non-cases.
Approximately, 50% of cardiac
events occur in non-cases without
traditional risk factors (Braunwald
1997). This proportion was 42%
in our study.
● In the “time to event analyses”
such as Cox regression, the risk is
calculated by the time to the
event, not by the proportion of
exposed in the population. Thus,
risk amplification described by
Sommerfelt et al. (2012) may not
be applicable when Cox regression
analyses are employed.
The recent American Heart Asso-
ciation (AHA) scientific statement
stipulated that there was no evidence
that periodontal treatment improved
cardiac outcomes citing inadequately
adjusted confounding factors such as
smoking and diabetes (Lockhart
et al. 2012). However, our results
appear to suggest that oral infection
may be an important contributor to
CRP levels. This observation is con-
sistent with the consensus statement
of The European Federation of Peri-
odontology and American Academy
of Periodontology on Periodontitis
and atherosclerotic cardiovascular
disease (Tonetti et al. 2013).
The fact that CRP levels ≥3 mg/L
were inversely associated with CVD
mortality suggests that in this elderly
cohort, 3 mg/L of CRP might
illustrate physiological ageing or its
anti-inflammatory function. CRP is
non-specific inflammatory marker
and it can be pro-inflammatory or
anti-inflammatory, (Marnell et al.
2005, Kushner & Agrawal 2007)
depending on the circumstances. Not-
ing the median CRP levels of 4.0 mg/
L among asymptomatic controls in
this cohort (Qvarnstrom et al. 2010)
and 4.2 mg/L in the asymptomatic
JUPITER cohort (Ridker et al. 2009),
the mortality discrimination beyond
this median level appears to be plausi-
ble. Moreover, CRP level defining
CVD mortality could be higher than
the levels defining incident CVD. It is
also plausible that when pro-inflam-
matory component of CRP was
explained by oral infections, the
remaining CRP might describe its
anti-inflammatory functions. Some of
CRP’s anti-inflammatory functions
include its inhibitory actions against
neutrophil leucocytes’ (PMNs) activi-
ties: suppressing the chemotaxis of
PMNs to both IL-8 and bacterial che-
motactic peptide (Zhong et al. 1998);
and the production of reactive oxygen
species and degranulation (Dobrinich
& Spagnuolo 1991); inhibition of neu-
trophil movement by decreasing mito-
gen-activated protein kinases (MAP
kinase) (Yates-Siilata et al. 2004).
To explore the level where the
pro- and anti-inflammatory actions
of CRP intersect, we assessed the
HRs for CVD mortality associated
with a small increment of CRP level
keeping CRP ≤ 2 mg as a reference
(the same as the JUPITER trial). At
CRP level 3–4 mg/L, the HR was
0.24; at 5 mg/L, 0.56; at 6–8 mg/L,
1.06 and at above 8 mg/L, the HR
was 1.54 controlling for age, sex,
smoking and the number of teeth.
These results suggested that the rela-
tionship of CRP to CVD mortality
had changed its direction from
inverse to positive with CRP levels
at 6 mg/L and above. This can be
interpreted that CRP was associated
with better CVD survival (inverse) at
the lower levels and with the
increased risk for CVD deaths (posi-
tive) at CRP levels higher than
5 mg/L. It should be noted that the
median baseline CRP level for those
who survived after 15.8 years of fol-
low-up was 5 mg/L (Table 1) and
this level might indicate the CRP
level associated with physiological
ageing in this cohort (Kushner &
Sehgal 2002, Schrager et al. 2007,
Cartier et al. 2009).
One point to note is that many
previous studies reporting CRP as a
CVD risk marker did not control for
oral infections. The statin adminis-
tration at this low level of CRP ≥ 2
or 3 mg/L has been criticized by oth-
ers (Ray 2010, Ray et al. 2010, Ma-
scitelli & Goldstein 2012, 2013),
because statin administration accom-
panies some serious adverse effects
including the risk of increased diabe-
tes incidence (Ridker et al. 2008,
Sattar et al. 2010).
Good oral hygiene practice was
associated with longevity in a popu-
lation-based cohort (Paganini-Hill
et al. 2011). Our results are consis-
tent with this report showing that
good oral self-care was also associ-
ated with significantly improved
CVD survival (HR = 0.41, p = 0.04)
which was mediated by the number
of teeth. Regarding access to dental
care in our cohort, 95% of our study
participants had public or private
dental care coverage. Thus, access to
dental care does not appear to be a
problem in Finland.
Socioeconomic status has been
implicated as a confounding factor
for the relationship of oral health
and cardiovascular health (Sabbah
et al. 2008). However, in our analy-
ses, adjusting for education did not
materially alter the relationship of
number of teeth and CVD mortality.
Our results are consistent with other
studies from Scandinavia where the
living standard is high and access to
healthcare is adequate (Cabrera et al.
2005, Heitmann & Gamborg 2008).
Strengths
Firstly, small sample size can be both
a limitation and strength. In large
studies, any nebulous risk factors will
appear as significant, because the p-
value is a function of sample size
(Gardner & Altman 1986). However,
our small sample size enabled us to
distinguish subtle differences such as
changes in the direction of CRP rela-
tive to mortality. The second strength
is the homogeneous Finnish ethnicity
and uniformly high living standard
that minimized confounding by the
SES factors.
Limitations
The first limitation is that baseline
data were collected only once and we
have no information on the changes
in some time-varying variables. The
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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second limitation is that we do not
have information on non-fatal cardiac
events and the difference between
fatal and non-fatal cardiac events
could not be assessed. The third limi-
tation is the small sample size that did
not allow testing the interaction terms
and conducting stratified analyses if
effect modification was evident. How-
ever, we were able to adjust most
important risk factors albeit in sim-
pler linear forms to avoid model over-
fitting. The final limitation is that
because this is not a population-based
study, our results may not be applica-
ble to general populations. However,
our population risk estimates in simu-
lated data appear to support the gen-
eralizability of our results.
Conclusion
Based on the results of this longitu-
dinal study, a higher baseline tooth
count was associated with increased
CVD survival. This improved sur-
vival was independent of CRP level
≥3 mg/L or fibrinogen ≥3 g/L. How-
ever, the association between the
number of teeth and CVD mortality
appeared to be mediated by high
CRP levels (>5 mg/L). Future larger
studies are warranted.
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Clinical Relevance
Scientific rationale for the study:
Does the number of teeth, as an
inverse proxy of oral inflammation
predict longevity and was this rela-
tionship mediated through systemic
inflammation?
Principal findings: Each increment
of 10 teeth from the edentulous
state was associated with a 27%
improvement in CVD survival. The
inverse association of tooth count on
CVD mortality was independent of
systemic inflammation assessed by
C-reactive protein ≥3 mg/L or fibrin-
ogen. However, there appeared to be
mediation effects of CRP levels
>5 mg/L.
Practical implications: Maintaining
many healthy teeth may be associ-
ated with longer CVD survival.
When the number of remaining
teeth (oral infection proxy) is con-
trolled, CRP level ≥3 mg/L was
inversely associated with CVD
mortality. Approximately, 26% of
the association between the number
of teeth and CVD survival might
be mediated by CRP levels >5 mg/
L in this cohort.
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